Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

Fig. 1

Genomic landscape and multivariable survival analysis in 852 patients with de novo myelodysplastic syndromes. A The frequency of mutated genes in 852 patients with de novo MDS. Lesions observed in more than five patients are shown. Colors represent different 2016 WHO subtypes. B Significant variables in multivariable analysis in 852 subjects with de novo MDS. Abbreviations: MDS: myelodysplastic syndrome; MDS-U: unclassified MDS; SLD: single-lineage dysplasia; MLD: multilineage dysplasia; RS: ring sideroblasts; EB: excess blasts; WHO: World Health Organization; BM: bone marrow; IPSS-R: International Prognostic Scoring System-Revised

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us